As COVID Deaths Rise Worldwide, “American Covid” Variant Raises Questions About Eye Symptoms

COVID-19 continues to circulate worldwide, even as many countries have moved away from emergency-era restrictions. Recent surveillance updates have renewed attention on XFG, a recombinant Omicron subvariant sometimes referred to online as “Stratus” or “American Covid,” as well as on the possibility that eye irritation and conjunctivitis may occur alongside more familiar respiratory symptoms.

Public-health experts emphasize that variant nicknames can be misleading. “American Covid” is not an official scientific or medical name, and a variant’s presence in the United States does not mean it originated there or causes a uniquely American form of illness. Health agencies use technical lineage names, such as XFG, to track changes in the virus and assess whether those changes affect transmission, disease severity, testing, vaccines or treatments.

The broader message from health authorities remains consistent: SARS-CoV-2, the virus that causes COVID-19, has not disappeared. While population immunity from vaccination and previous infection has reduced the overall burden of severe disease compared with the earliest years of the pandemic, older adults, people with weakened immune systems and those with certain chronic medical conditions can still face a higher risk of hospitalization or death.

COVID-19 Surveillance Still Matters

COVID-19 surveillance looks different than it did during the height of the pandemic. Many countries have scaled back widespread testing, routine reporting and public dashboards. As a result, confirmed case counts now capture only part of the virus’s actual spread. People may test at home, choose not to test, or have symptoms mild enough that they do not seek medical care.

For that reason, public-health agencies increasingly rely on several indicators rather than a single daily case total. These can include hospital admissions, emergency department visits, laboratory test positivity, deaths reported through national systems and wastewater monitoring. Each measure has limitations, but together they can reveal whether transmission is rising or falling in a community.

Wastewater monitoring has become particularly useful because infected people can shed viral material before they seek care or take a test. It does not identify individual patients, but it can provide an early community-level signal that COVID-19 activity is changing. In the United States, the Centers for Disease Control and Prevention and partner programs use wastewater data alongside clinical reporting to estimate trends.

Global data should also be interpreted carefully. The World Health Organization has repeatedly noted that reported infections and deaths vary according to national testing practices, reporting schedules and the availability of health services. A rise in reported deaths over a short period may warrant close attention, but it does not automatically establish that a specific variant is more dangerous. Researchers need additional evidence, including hospitalization data, age distribution, vaccination coverage and comparisons with other circulating lineages.

What Is XFG, Sometimes Called Stratus?

XFG is a recombinant SARS-CoV-2 lineage. Recombinant variants can emerge when two related viral lineages infect the same person and exchange genetic material during replication. This is a recognized feature of coronavirus evolution and does not, by itself, mean a variant is more severe or more resistant to immunity.

Like other Omicron descendants, XFG has attracted attention because changes in its spike protein may help it spread in populations that already have some immune protection from vaccines, prior infection or both. However, increased transmission does not necessarily translate into more serious illness for an individual patient. A variant may become common because it has a modest transmission advantage, because immunity has changed over time, or because it happens to be introduced into the right networks at the right moment.

Health agencies such as the WHO, the CDC and the UK Health Security Agency monitor new lineages continuously. Their assessments consider genetic sequencing, laboratory studies and real-world outcomes. When available evidence does not show greater severity, officials generally advise the public to use the same practical precautions recommended for other circulating COVID-19 variants rather than treating a new nickname as a separate disease.

Common Symptoms Remain Similar to Other COVID-19 Infections

Most symptoms associated with XFG appear broadly similar to symptoms reported with other recent Omicron-lineage infections. COVID-19 can resemble a cold, influenza, allergies or another respiratory infection, which is why testing may be useful for people at higher risk of complications or those who may expose vulnerable individuals.

Common symptoms can include:

• Sore throat
• Cough
• Runny or blocked nose
• Fever or chills
• Fatigue
• Headache and body aches
• Changes in taste or smell, although these are reported less consistently than earlier in the pandemic
• Nausea, vomiting or diarrhea in some people

Some people report a particularly uncomfortable sore throat during COVID-19 infection, but sore throat severity alone cannot identify a specific variant. Strep throat, influenza, common cold viruses, seasonal allergies and bacterial infections can also cause throat pain. A clinician can help determine whether testing or treatment is appropriate, especially if symptoms are severe, persistent or accompanied by trouble swallowing or breathing.

People with mild illness can often recover at home with rest, fluids and symptom relief recommended by a healthcare professional or pharmacist. However, people who are older, immunocompromised, pregnant, or living with conditions such as heart disease, chronic lung disease, diabetes or kidney disease may benefit from contacting a healthcare provider promptly after symptoms begin. Antiviral treatments work best when started early and may reduce the risk of severe outcomes for eligible patients.

Can COVID-19 Cause Red, Watery or Irritated Eyes?

Eye symptoms have been reported in some people with COVID-19 since the beginning of the pandemic. These symptoms may include redness, tearing, irritation, a gritty sensation, sensitivity to light or discharge. In some cases, the symptoms resemble conjunctivitis, commonly called pink eye.

Conjunctivitis is inflammation of the conjunctiva, the thin membrane that covers the white part of the eye and lines the inside of the eyelids. It has many possible causes. Viruses, bacteria, allergies, irritants and contact lens problems can all lead to red or uncomfortable eyes. Because these causes require different approaches, red eyes should not automatically be assumed to be a sign of COVID-19.

Medical reviews have found that ocular symptoms can occur in a minority of people with confirmed COVID-19. Estimates differ widely across studies because researchers have examined different patient groups, settings and definitions of eye involvement. Eye symptoms are more often reported alongside other signs of infection than as the only symptom, although isolated cases have been described.

The scientific evidence supports a cautious conclusion: conjunctivitis can occur during COVID-19, but it is not among the most specific or most common signs of infection. Someone with red, itchy eyes during allergy season may have allergies. Someone with a sticky discharge may have bacterial or viral conjunctivitis unrelated to COVID-19. A person with eye irritation plus fever, cough, fatigue or a known exposure may reasonably consider a COVID-19 test, particularly if they are at higher risk or live with vulnerable people.

When Eye Symptoms Need Medical Attention

Most mild eye irritation is not an emergency, but certain symptoms should be assessed urgently. The American Academy of Ophthalmology and other clinical authorities advise seeking prompt medical care for severe eye pain, sudden vision changes, marked light sensitivity, significant swelling around the eye, injury to the eye, or redness associated with a severe headache or nausea. Contact lens wearers with a painful red eye should be especially cautious because some infections can threaten vision if left untreated.

People with suspected infectious conjunctivitis can help limit spread by washing hands often, avoiding touching or rubbing their eyes, not sharing towels or cosmetics, and cleaning commonly touched surfaces. Contact lenses should generally not be worn while the eye is red or irritated unless an eye-care professional advises otherwise. It is also sensible to avoid using antibiotic eye drops without medical guidance, because antibiotics do not treat viral or allergic conjunctivitis.

There is no strong basis for assuming that eye symptoms mean the coronavirus has reached deeper structures of the eye. Researchers have explored how SARS-CoV-2 may interact with tissues around the eye, but serious eye complications are uncommon. Clear, evidence-based communication is important because alarming claims can cause unnecessary anxiety and may distract from more practical steps, such as testing when appropriate and seeking timely care for concerning symptoms.

Protecting Higher-Risk People During COVID-19 Waves

COVID-19 prevention no longer depends on a single universal rule. Instead, individuals can make informed choices based on local transmission, their health status and the needs of people around them. Vaccination remains an important tool for reducing the risk of severe illness, particularly for older adults and those with underlying medical conditions. Recommendations differ by country, so people should consult their national health authority or healthcare provider for current eligibility and timing.

Additional precautions can be useful when respiratory viruses are spreading. These include staying home when ill where possible, improving ventilation, wearing a well-fitting mask in crowded indoor settings when personal risk is high, and testing before visiting someone who is medically vulnerable. Employers, schools and communities can support these choices by encouraging people to stay home when sick and by improving indoor air quality.

People who develop symptoms should pay attention to their overall condition rather than focusing only on the name of a circulating variant. Emergency help is needed for warning signs such as difficulty breathing, persistent chest pain or pressure, new confusion, inability to stay awake, or pale, gray or blue-colored lips, skin or nail beds depending on skin tone. These signs can indicate a serious medical emergency and should not be managed solely through online information.

Why Accurate Variant Information Is Important

New COVID-19 labels can spread quickly on social media, especially when they are linked to a country or an unusual symptom. But scientific monitoring is more reliable than viral headlines. A responsible assessment asks whether health authorities have identified a rise in transmission, whether hospitals are seeing more severe disease, and whether vaccines or treatments continue to offer protection.

For now, the practical facts are familiar: COVID-19 remains a circulating respiratory illness; new variants are expected as the virus evolves; and symptoms can vary from person to person. Red or watery eyes may occur in some cases, but they are not enough on their own to diagnose COVID-19. Testing, clinical advice and up-to-date public-health guidance remain the best tools for making informed decisions.

Sources

• World Health Organization: COVID-19 information and surveillance
• U.S. Centers for Disease Control and Prevention: COVID-19 guidance and data
• CDC National Wastewater Surveillance System
• UK Health Security Agency
• American Academy of Ophthalmology: Eye health information
• Mayo Clinic: Conjunctivitis symptoms and causes